Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
4.880
-0.360 (-6.87%)
At close: May 21, 2025, 4:00 PM
4.850
-0.030 (-0.61%)
After-hours: May 21, 2025, 4:00 PM EDT
Cryo-Cell International Employees
As of November 30, 2024, Cryo-Cell International had 86 total employees, including 82 full-time and 4 part-time employees. The number of employees decreased by 2 or -2.27% compared to the previous year.
Employees
86
Change (1Y)
-2
Growth (1Y)
-2.27%
Revenue / Employee
$373,288
Profits / Employee
$1,497
Market Cap
39.44M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CCEL News
- 12 days ago - Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend - Business Wire
- 2 months ago - Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024 - Business Wire
- 3 months ago - Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives - Business Wire
- 7 months ago - Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend - Business Wire
- 7 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results - Business Wire
- 11 months ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results - Business Wire
- 1 year ago - Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results - Business Wire
- 1 year ago - Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value - Business Wire